Differences

This shows you the differences between two versions of the page.

--- covid-19_immunity_task_force [2022/04/24 10:49]
liam [Team]
+++ covid-19_immunity_task_force [2022/10/27 19:39] (current)
liam [Ontario study]
@@ Line 5: / Line 5: @@
 The **COVID-19 Immunity Task Force** is a Canadian initiative intended to organize resources to study natural and vaccine-induced immunity to [[SARS-CoV-2]].
+It was launched in April 2020 by the [[Government of Canada]].((//COVID-19 Immunity Task Force.// (2021, October 21). McGill University School of Population and Global Health. https://archive.ph/o6M3j)) The group is jointly funded by the [[Canadian Institutes of Health Research]] (CIHR) and the [[Public Health Agency of Canada]] (PHAC).((Nelson, M. (2020, September 10). //Canada’s COVID-19 Immunity Task Force partners with CIHR to support 22 studies investigating COVID-19.// COVID-19 Immunity Task Force. https://www.covid19immunitytaskforce.ca/canadas-covid-19-immunity-task-force-partners-with-cihr-to-support-22-studies-investigating-covid-19-2/))
+===== Research =====
+As of March 23, 2022, the CITF is supporting 112 [[COVID-19]] studies across Canada.((Evans, T. (2022, March 23). //The importance of pediatric vaccination.// COVID-19 Immunity Task Force. https://web.archive.org/web/20220403062829/https://www.covid19immunitytaskforce.ca/wp-content/uploads/2022/03/CITF_CanCOVID_6_Pediatric-vaccination_2022_EN_FINAL-2.pdf))
+==== COVERED study ====
+COVERED is a [[COVID-19 vaccines|COVID-19 vaccine]] registry for pregnant and breastfeeding women across Canada.((Burns, R., Logothetis, P., & Rolfsen, E. (2021, May 19). //Canadian researchers studying effectiveness and safety of COVID-19 vaccines during pregnancy.// COVID-19 Immunity Task Force. https://archive.ph/21EZi))
+It is being run at the [[University of British Columbia]] in partnership with [[Canadian Vaccine Safety Network]] (CANVAS), the [[Public Health Agency of Canada]] and the [[Women's Health Research Institute]].((//Home | Canadian COVID-19 Vaccine Registry for Pregnant and Lactating Individuals.// University of British Columbia. Retrieved June 20, 2022, from https://archive.ph/REwD1)) The lead researcher is [[Deborah Money]].
+An additional "Immune-Substudy" was launched at the [[British Columbia Women's Hospital]].((//Immune Sub-Study | Canadian COVID-19 Vaccine Registry for Pregnant and Lactating Individuals.// University of British Columbia. Retrieved June 20, 2022, from https://covered.med.ubc.ca/immune-sub-study/))
+==== Ontario study ====
+This second study links information collected from [[BORN Ontario]], which collects data from every baby born in Ontario, with the province’s vaccination registry from the [[Ontario Ministry of Health]] ([[COVaxON]]). [[Deshayne Fell]] is the lead researcher.
 ===== Affiliations =====
+The secretariat for the task force is housed at the [[McGill University School of Population and Global Health.]]((//COVID-19 Immunity Task Force.// (2021, October 21). McGill University School of Population and Global Health. https://archive.ph/o6M3j))
 ==== Team ====
@@ Line 16: / Line 35: @@
 | [[Mona Nemer]]  | Executive Committee; Government of Canada representative  | [[Government of Canada]]  | Chief Science Advisor of Canada  |
 | [[Howard Njoo]]  | Executive Committee  | [[Public Health Agency of Canada]]  | Deputy Chief Public Health Officer and Interim Vice-President, Infectious Disease Programs Branch  |
-| [[Gina Ogilvie]]  | Executive Committee  | [[University of British Columbia]], [[BC Centre for Disease Control]], [[Women's Health Research Institute]]  | -  |
+| [[Gina Ogilvie]]  | Executive Committee, Leadership Team  | [[University of British Columbia]], [[BC Centre for Disease Control]], [[Women's Health Research Institute]]  | -  |
-| [[Jutta Preiksaitis]]  | Executive Committee  | [[University of Alberta]]  | -  |
+| [[Jutta Preiksaitis]]  | Executive Committee, Leadership Group  | [[University of Alberta]]  | -  |
-| [[Gail Tomblin Murphy]] | Executive Committee  | [[Nova Scotia Health Authority]]  | -  |
+| [[Gail Tomblin Murphy]] | Executive Committee, Leadership Group  | [[Nova Scotia Health Authority]]  | -  |
-| [[Paul van Caeseele]]  | Executive Committee  | [[Cadham Provincial Laboratory]], [[Manitoba Health]], [[University of Manitoba]]  | -  |
+| [[Paul van Caeseele]]  | Executive Committee, Leadership Group  | [[Cadham Provincial Laboratory]], [[Manitoba Health]], [[University of Manitoba]]  | -  |
 | [[Theresa Tam]]  | [[Government of Canada]] representative  | [[Public Health Agency of Canada]]  | -  |
 | [[Stephen Lucas]]  | [[Government of Canada]] representative  | [[Health Canada]]  | -  |
@@ Line 33: / Line 52: @@
 | [[Richard Massé]]  | Leadership Group  | [[Government of Quebec]]  | -  |
 | [[Allison McGeer]]  | Leadership Group  | [[University of Toronto]]  | -  |
+| [[Deborah Money]]  | Leadership Group  | [[University of British Columbia]], [[Women's Health Research Institute]]  | -  |
+| [[Shelly Bolotin]]  | Provincial & Territorial representative  | [[Public Health Ontario]] (PHO)  | -  |
+| [[Marguerite Cameron]]  | Provincial & Territorial representative  | [[PEI Health and Wellness]]  | -  |
+| [[Catherine Elliot]]  | Provincial & Territorial representative  | [[Government of Yukon]]  | -  |
+| [[Richard Garceau]]  | Provincial & Territorial representative  | [[Dr. Georges L Dumont University Hospital Centre]]  | -  |
+| [[Jessica Minion]]  | Provincial & Territorial representative  | [[Saskatchewan Health Authority]]  | -  |
+| [[Michael Patterson]]  | Provincial & Territorial representative  | [[Government of Nunavut]]  | -  |
+| [[Nathan Stall]]  | -  | [[Ontario COVID-19 Science Advisory Table]], [[CanCOVID]], [[Sinai Health System]], [[Ontario Liberal Party]]  | Received funding from the Task Force for geriatric research.((Stall, N. M. (2021, January 29). //Declaration of Interest.// Wayback Machine; Ontario COVID-19 Science Advisory Table. https://web.archive.org/web/20210425034556/https://covid19-sciencetable.ca/wp-content/uploads/2021/01/Declaration-of-Interest_Science-Table_Nathan-Stall-2.pdf))  |